期刊文献+

siRNA干扰USP7表达对喉癌细胞生物学特性的影响 被引量:2

Influence of siRNA interfering USP7 expression on cytobiological characteristics of laryngeal cancer cells
暂未订购
导出
摘要 目的通过小干扰RNAs(siRNA)干扰泛素特异性蛋白酶7(USP7)在喉癌细胞中的表达,来探讨USP7对喉癌细胞生物学特性的影响。方法自行设计并使用高效siRNA在喉癌HEP2细胞株特异性干扰USP7表达,然后利用CCK-8法、Transwell小室迁移实验和流式细胞术观察USP7干扰后对喉癌细胞增殖、迁移能力和凋亡的影响。结果自行设计的siRNA可高效抑制喉癌HEP2细胞USP7mRNA及蛋白表达,显著抑制喉癌细胞的增殖、迁移能力,促进喉癌细胞的凋亡。结论 siRNAUSP7可以显著抑制喉癌细胞增殖和迁移能力,并促进凋亡,提示USP7可能是晚期喉癌治疗的一个重要靶标。 Objective This study is to investigate the influences of USP7 on the cytobiological characteristics of laryngeal cancer cells by small interfering RNA(siRNA)interfering the USP7 expression in the laryngeal cancer cells.Methods The self-designed highly efficient siRNA was used to conduct the specific interference on USP7 expression in laryngeal cancer HEP2 cells.Then the influence on the capacity of cell proliferation and migration,as well as apoptosise after USP7 interference were observed by using the CCK-8method,Transwell chamber migration test and flow cytometry.Results The self-designed siRNA could efficiently inhibit the expression of USP7 mRNA in laryngeal cancer cells,furthermore markedly suppressed the proliferation and migration of laryngeal cancer cells,enhanced the cell apoptosis in laryngeal cancer HEP2 cells in vitro.Conclusion The siRNA interfering USP7 can inhibit the proliferation and migration capacity of laryngeal cancer cells,and promoted their apoptosis.
出处 《重庆医学》 CAS 北大核心 2016年第12期1616-1619,共4页 Chongqing medicine
关键词 喉肿瘤 泛素特异性蛋白酶7 HEP2细胞 RNA 小分子干扰 细胞凋亡 laryngeal neoplasms ubiquitin-specific protease 7 HEP2cell line RNA small interfering apoptosis
  • 相关文献

参考文献21

  • 1符晓,李赞,王大海,陈志勇,谢珂,龚兴宏.综合治疗9例喉癌术后咽瘘的疗效分析[J].中国耳鼻咽喉颅底外科杂志,2012,18(4):305-306. 被引量:6
  • 2Li L,Zhang Z,Wang C,et al. Quantitative proteomics ap proach to screening of potential diagnostic and therapeutictargets for laryngeal carcinoma[J]. PLoS One, 2014, 9 (2) :e90181.
  • 3Kar G,Keskin O,Fraternali F,et al. Emerging role of the ubiquitin-proteasome system as drug targets [J]. Curr Pharm Des,2013,19(18) :3175-3189.
  • 4周芨,邓世山,刘海.USP7在喉癌组织中的表达及其临床意义[J].中国耳鼻咽喉颅底外科杂志,2015,21(1):27-30. 被引量:7
  • 5Higuchi Y,Kawakami S, Hashida M. Strategies for in vi- vo delivery of siRNAs: recent progress[J]. Bio Drugs, 2010,24(3) .. 195-205.
  • 6Ren T, Qing Y, Dai N, et al. Apurinic/apyrimidinic endo- nuclease 1 induced upregulation of fibroblast growth fac- tor 2 and its receptor 3 induces angiogenesis in human os- teosareoma cells[J]. Cancer Sci, 2014,105 (2) : 186-194.
  • 7Karatzanis AD, Psychogios G, Waldfahrer F, et al. Man- agement of locally advanced laryngeal cancer[J]. J Otolar- yngol Head Neck Surg,2014,43(1) ..4.
  • 8Spector GJ, Sessions DG, Lenox J, et al. Management of stage IV glottic carcinoma: therapeutic outcomes[J]. La- ryngoscope, 2004,114(8) : 1438-1446.
  • 9Keszte J, Danker H, Dietz A, et al. Mental disorders and psychosocial support during the first year after total lar- yngectomy[J]. Clin Ototaryngol, 2013,38 (6) .. 494-501.
  • 10Starmer HM,Tippett DC, Webster KT. Effects of laryn- geal cancer on voice and swallowing[J]. Otolaryngol Clin North Am, 2008,41 (4) .. 793-818, vii.

二级参考文献19

  • 1瞿丽,陈辉,叶金明.康复新在老年慢性溃疡患者中的应用[J].华西药学杂志,2004,19(6):483-483. 被引量:37
  • 2屠规益.头颈部恶性肿瘤颈淋巴转移的治疗方案和手术命名(2004年,大连)[J].中华耳鼻咽喉头颈外科杂志,2005,40(2):84-86. 被引量:70
  • 3Li L, Zhang Z, Wang C, et al. Quantitative proteomics approach to screening of potential diagnostic and therapeutic targets for laryngeal carcinoma[J]. PloS one, 2014,9(2) :e90181.
  • 4Nicholson B, Suresh Kumar KG. The multifaceted roles of USP7: new therapeutic opportunities [ J ]. Cell biochemistry and biophys- ics, 2011,60(1 -2) :61 -68.
  • 5Hershko A, Ciechanover A. The ubiquitin system [ J ]. Annu Rev Biochem, 1998,67:425 - 479.
  • 6Reyes-Turcu FE, Ventii KH, Wilkinson KD. Regulation and cellu- lar roles of ubiquitin-specific deubiquitinating enzymes [ J 1. Annu Rev Biochem, 2009,78:363 - 397.
  • 7Everett RD, Meredith M, Orr A, et al. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein [ J ]. The EMBO Journal, 1997,16(7) :1519 - 1530.
  • 8Li M, Chert D,Shiloh A, et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization[ J]. Nature, 2002,416 (6881) :648 -653.
  • 9Meulmeester E, Mauriee MM, Boutell C, et al. Loss of HAUSP-medi- ated deubiquitination contributes to DNA damage-induced destabili- zation of Hdmx and Hdm2[J]. Molecular cell, 2005,18(5) :565 - 576.
  • 10Cheng C, Niu C, Yang Y, et al. Expression of HAUSP in gliomas correlates with disease progression and survival of patients [ J ]. On- cology reports, 2013,29 (5) : 1730 - 1736.

共引文献11

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部